Skip to main content
Log in

The concern about noradrenergic and antimuscarinic agents for OSA

  • Letter to the Editor
  • Published:
Sleep and Biological Rhythms Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA, Eckert DJ, White DP, Wellman A. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med. 2019;199(10):1267–76. https://doi.org/10.1164/rccm.201808-1493OC.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial. J Physiol. 2021. https://doi.org/10.1113/JP281912.

    Article  PubMed  Google Scholar 

  3. Aishah A, Lim R, Sands SA, Taranto-Montemurro L, Wellman A, Carberry JC, Eckert DJ. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity. J Appl Physiol (1985). 2021;130(5):1373–82. https://doi.org/10.1152/japplphysiol.01074.2020.

    Article  CAS  Google Scholar 

  4. Tempesta D, Socci V, De Gennaro L, Ferrara M. Sleep and emotional processing. Sleep Med Rev. 2018;40:183–95. https://doi.org/10.1016/j.smrv.2017.12.005.

    Article  PubMed  Google Scholar 

  5. Eckert DJ, Owens RL, Kehlmann GB, Wellman A, Rahangdale S, Yim-Yeh S, White DP, Malhotra A. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (1979). 2011;120(12):505–14. https://doi.org/10.1042/CS20100588.

    Article  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of Guangdong Province China (No.2019A1515010981). The funding bodies had no role in design, data collection and analysis, or interpretation of the findings.

Author information

Authors and Affiliations

Authors

Contributions

DW is the primary author of this letter. RC generated the original concept and searched for information. NZ revised this letter.

Corresponding author

Correspondence to Nuofu Zhang.

Ethics declarations

Conflict of interest

None reported.

Consent for publication

All authors have seen and approved the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, D., Chen, R. & Zhang, N. The concern about noradrenergic and antimuscarinic agents for OSA. Sleep Biol. Rhythms 20, 319–320 (2022). https://doi.org/10.1007/s41105-021-00367-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41105-021-00367-0

Navigation